Woodline Partners »

Poseida Therapeutics I shares owned by Woodline Partners

Quarter-by-quarter ownership of Poseida Therapeutics I (PSTX) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Poseida Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Poseida Therapeutics I held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Poseida Therapeutics I by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.4M 479k 2.86

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Poseida Therapeutics I

Pentwater Capital Management
BlackRock
BlackRock
Silverarc Capital Management
Vanguard Group
Boxer Capital
State Street Corporation
Geode Capital Management
William Blair $ Company
Aisling Capital Management
Renaissance Technologies
Acadian Asset Management
Jacobs Levy Equity Management
Charles Schwab Investment Management
Northern Trust

View all funds holding Poseida Therapeutics I